

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.61177048 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.30424990 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.27533148 |
| 4 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.23954445 |
| 5 | vocalization behavior (GO:0071625) | 5.13418949 |
| 6 | glutamate secretion (GO:0014047) | 5.11562078 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.10457278 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.02063069 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.98430577 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.91049326 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.85440689 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.73052509 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.67092604 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.52291918 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.44672205 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.41363535 |
| 17 | protein localization to synapse (GO:0035418) | 4.36091258 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.33017443 |
| 19 | neurotransmitter secretion (GO:0007269) | 4.32582512 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.30052510 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.09791160 |
| 22 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.08920381 |
| 23 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.08150734 |
| 24 | neuron-neuron synaptic transmission (GO:0007270) | 4.00766023 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 3.98628521 |
| 26 | presynaptic membrane assembly (GO:0097105) | 3.93377043 |
| 27 | long-term synaptic potentiation (GO:0060291) | 3.93237731 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.92697358 |
| 29 | gamma-aminobutyric acid transport (GO:0015812) | 3.84799894 |
| 30 | potassium ion homeostasis (GO:0055075) | 3.83869832 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.83327301 |
| 32 | exploration behavior (GO:0035640) | 3.81875387 |
| 33 | postsynaptic membrane organization (GO:0001941) | 3.79607698 |
| 34 | regulation of synapse structural plasticity (GO:0051823) | 3.77715480 |
| 35 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.75374573 |
| 36 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.72125405 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.63159160 |
| 38 | potassium ion import (GO:0010107) | 3.62213383 |
| 39 | auditory behavior (GO:0031223) | 3.61607333 |
| 40 | presynaptic membrane organization (GO:0097090) | 3.60327019 |
| 41 | long-term memory (GO:0007616) | 3.59011676 |
| 42 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.57660830 |
| 43 | cellular potassium ion homeostasis (GO:0030007) | 3.57195821 |
| 44 | neuronal ion channel clustering (GO:0045161) | 3.56357598 |
| 45 | response to auditory stimulus (GO:0010996) | 3.55882246 |
| 46 | response to histamine (GO:0034776) | 3.49712751 |
| 47 | regulation of synaptic plasticity (GO:0048167) | 3.48697689 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 3.48112049 |
| 49 | central nervous system myelination (GO:0022010) | 3.48025561 |
| 50 | axon ensheathment in central nervous system (GO:0032291) | 3.48025561 |
| 51 | neurotransmitter transport (GO:0006836) | 3.47138369 |
| 52 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.45713181 |
| 53 | positive regulation of membrane potential (GO:0045838) | 3.44321767 |
| 54 | proline transport (GO:0015824) | 3.44056991 |
| 55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.43082375 |
| 56 | neurotransmitter uptake (GO:0001504) | 3.41420852 |
| 57 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.40663829 |
| 58 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.40528163 |
| 59 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.39433802 |
| 60 | mechanosensory behavior (GO:0007638) | 3.38276054 |
| 61 | cellular sodium ion homeostasis (GO:0006883) | 3.37585249 |
| 62 | positive regulation of dendritic spine development (GO:0060999) | 3.37429106 |
| 63 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.37404737 |
| 64 | regulation of neurotransmitter secretion (GO:0046928) | 3.36014622 |
| 65 | cerebellar granule cell differentiation (GO:0021707) | 3.31972039 |
| 66 | membrane depolarization during action potential (GO:0086010) | 3.30496105 |
| 67 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.26330138 |
| 68 | positive regulation of neurotransmitter transport (GO:0051590) | 3.25362073 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.24172664 |
| 70 | positive regulation of synaptic transmission (GO:0050806) | 3.22651446 |
| 71 | activation of protein kinase A activity (GO:0034199) | 3.20655155 |
| 72 | dendritic spine organization (GO:0097061) | 3.18968145 |
| 73 | regulation of neurotransmitter transport (GO:0051588) | 3.18503562 |
| 74 | transmission of nerve impulse (GO:0019226) | 3.16999486 |
| 75 | layer formation in cerebral cortex (GO:0021819) | 3.16594334 |
| 76 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.15651753 |
| 77 | L-amino acid import (GO:0043092) | 3.14483324 |
| 78 | regulation of dendritic spine development (GO:0060998) | 3.14359457 |
| 79 | acidic amino acid transport (GO:0015800) | 3.12949183 |
| 80 | regulation of vesicle fusion (GO:0031338) | 3.08453335 |
| 81 | startle response (GO:0001964) | 3.07203098 |
| 82 | neuromuscular synaptic transmission (GO:0007274) | 3.06706644 |
| 83 | regulation of synaptic transmission (GO:0050804) | 3.01810686 |
| 84 | synaptic vesicle endocytosis (GO:0048488) | 3.00731538 |
| 85 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.00513703 |
| 86 | regulation of beta-amyloid formation (GO:1902003) | 3.00428581 |
| 87 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.00325666 |
| 88 | neuron recognition (GO:0008038) | 2.99627935 |
| 89 | synaptic vesicle transport (GO:0048489) | 2.98442151 |
| 90 | establishment of synaptic vesicle localization (GO:0097480) | 2.98442151 |
| 91 | axonal fasciculation (GO:0007413) | 2.98149080 |
| 92 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.98020637 |
| 93 | establishment of mitochondrion localization (GO:0051654) | 2.97605152 |
| 94 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.96653387 |
| 95 | neuromuscular process controlling posture (GO:0050884) | 2.96169239 |
| 96 | regulation of female receptivity (GO:0045924) | 2.95583242 |
| 97 | synaptic transmission (GO:0007268) | 2.94739514 |
| 98 | cell communication by electrical coupling (GO:0010644) | 2.94317288 |
| 99 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93139408 |
| 100 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.91758204 |
| 101 | membrane depolarization (GO:0051899) | 2.91718326 |
| 102 | neuromuscular process controlling balance (GO:0050885) | 2.91671266 |
| 103 | behavioral fear response (GO:0001662) | 2.91089555 |
| 104 | behavioral defense response (GO:0002209) | 2.91089555 |
| 105 | membrane hyperpolarization (GO:0060081) | 2.90381194 |
| 106 | female mating behavior (GO:0060180) | 2.90060099 |
| 107 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.89743687 |
| 108 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.89724122 |
| 109 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.88438810 |
| 110 | sodium ion export (GO:0071436) | 2.87888859 |
| 111 | regulation of synapse maturation (GO:0090128) | 2.87177708 |
| 112 | C4-dicarboxylate transport (GO:0015740) | 2.86096494 |
| 113 | learning (GO:0007612) | 2.86070802 |
| 114 | dendritic spine morphogenesis (GO:0060997) | 2.85793838 |
| 115 | amino acid import (GO:0043090) | 2.85779499 |
| 116 | synapse assembly (GO:0007416) | 2.85730358 |
| 117 | striatum development (GO:0021756) | 2.85702137 |
| 118 | detection of calcium ion (GO:0005513) | 2.84288625 |
| 119 | transferrin transport (GO:0033572) | 2.81660617 |
| 120 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.81643336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.26992347 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.92240216 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21941139 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16751216 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.87790326 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.66848498 |
| 7 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65346289 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64672285 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.59900787 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59321151 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.58134177 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.58134177 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50060742 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47915995 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46263966 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.42180465 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.41502562 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.24375800 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23726573 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14090376 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13311381 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11931008 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11877642 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.10622243 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.04218511 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89403753 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88066760 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86166103 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.85670875 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82394425 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77905223 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77324655 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75297427 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71370814 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71074138 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.69424625 |
| 37 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.67483419 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62746353 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.58624508 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45762480 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42933779 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42448312 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40232637 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39404160 |
| 45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37905729 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37503178 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36850006 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33599083 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33402278 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32270216 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31994067 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31393154 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29340835 |
| 54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28085299 |
| 55 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26901592 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26183833 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25009007 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24989405 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23813348 |
| 60 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19659788 |
| 61 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18570412 |
| 62 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17721813 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15416978 |
| 64 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15308285 |
| 65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15030138 |
| 66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11644318 |
| 67 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07945595 |
| 68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07809988 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07220058 |
| 70 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06259601 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06207265 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05854899 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05835972 |
| 74 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05781083 |
| 75 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.04046779 |
| 76 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03376471 |
| 77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03276513 |
| 78 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03070675 |
| 79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02834075 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02383434 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01453431 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00725081 |
| 83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00402275 |
| 84 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99859915 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97146510 |
| 86 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96801811 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95615889 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95401100 |
| 89 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95170910 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95160004 |
| 91 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94630975 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93688284 |
| 93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93166698 |
| 94 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92295658 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90796235 |
| 96 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89998415 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89621891 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89403730 |
| 99 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.89233678 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88537785 |
| 101 | JUN_21703547_ChIP-Seq_K562_Human | 0.88319376 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88307053 |
| 103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88240320 |
| 104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88240320 |
| 105 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87504166 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85956302 |
| 107 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85047660 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84010152 |
| 109 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83480047 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83237551 |
| 111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.81211988 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.79962171 |
| 113 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.79267557 |
| 114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.79246416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.66027270 |
| 2 | MP0003880_abnormal_central_pattern | 4.51378598 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.94062479 |
| 4 | MP0009745_abnormal_behavioral_response | 3.42818585 |
| 5 | MP0004270_analgesia | 3.27363085 |
| 6 | MP0002064_seizures | 3.21469962 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.20020361 |
| 8 | MP0009046_muscle_twitch | 3.15857601 |
| 9 | MP0002822_catalepsy | 2.98726543 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.89096498 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.88945450 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.73836634 |
| 13 | MP0001486_abnormal_startle_reflex | 2.59181876 |
| 14 | MP0002272_abnormal_nervous_system | 2.58538880 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.56012182 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.48039896 |
| 17 | MP0002736_abnormal_nociception_after | 2.47301075 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.30738428 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.23923647 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.03486015 |
| 21 | MP0003329_amyloid_beta_deposits | 2.02645566 |
| 22 | MP0002067_abnormal_sensory_capabilities | 1.97348766 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.96783327 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.94284269 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.92664118 |
| 26 | MP0001970_abnormal_pain_threshold | 1.87774855 |
| 27 | MP0008569_lethality_at_weaning | 1.87702179 |
| 28 | MP0001984_abnormal_olfaction | 1.82994307 |
| 29 | MP0004858_abnormal_nervous_system | 1.77035595 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.76155440 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.73201255 |
| 32 | MP0003879_abnormal_hair_cell | 1.71930586 |
| 33 | MP0003787_abnormal_imprinting | 1.66946877 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.66230673 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.61785143 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.60172162 |
| 37 | MP0004924_abnormal_behavior | 1.60172162 |
| 38 | MP0004885_abnormal_endolymph | 1.55906385 |
| 39 | MP0002184_abnormal_innervation | 1.51957952 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.48909840 |
| 41 | MP0001529_abnormal_vocalization | 1.47813033 |
| 42 | MP0003633_abnormal_nervous_system | 1.44377304 |
| 43 | MP0003122_maternal_imprinting | 1.43601808 |
| 44 | MP0004811_abnormal_neuron_physiology | 1.43062181 |
| 45 | MP0000778_abnormal_nervous_system | 1.40638295 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.33011479 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.31130039 |
| 48 | MP0000955_abnormal_spinal_cord | 1.29949716 |
| 49 | MP0001905_abnormal_dopamine_level | 1.27607834 |
| 50 | MP0000920_abnormal_myelination | 1.25044917 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.24464822 |
| 52 | MP0004142_abnormal_muscle_tone | 1.24236882 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.22152875 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.19876296 |
| 55 | MP0003631_nervous_system_phenotype | 1.19800239 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 1.15317305 |
| 57 | MP0003690_abnormal_glial_cell | 1.14683997 |
| 58 | MP0004043_abnormal_pH_regulation | 1.14645043 |
| 59 | MP0001188_hyperpigmentation | 1.12879395 |
| 60 | MP0000751_myopathy | 1.04475747 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.03860665 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.03276541 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.01715474 |
| 64 | MP0003121_genomic_imprinting | 1.01278076 |
| 65 | MP0003123_paternal_imprinting | 0.98185926 |
| 66 | MP0004215_abnormal_myocardial_fiber | 0.97951531 |
| 67 | MP0002069_abnormal_eating/drinking_beha | 0.95487551 |
| 68 | MP0002229_neurodegeneration | 0.95144104 |
| 69 | MP0002152_abnormal_brain_morphology | 0.94862357 |
| 70 | MP0003075_altered_response_to | 0.93559530 |
| 71 | MP0003634_abnormal_glial_cell | 0.91417868 |
| 72 | MP0004147_increased_porphyrin_level | 0.91331438 |
| 73 | MP0004085_abnormal_heartbeat | 0.91283944 |
| 74 | MP0001963_abnormal_hearing_physiology | 0.90394679 |
| 75 | MP0000604_amyloidosis | 0.89571175 |
| 76 | MP0008872_abnormal_physiological_respon | 0.87382347 |
| 77 | MP0001485_abnormal_pinna_reflex | 0.86505718 |
| 78 | MP0002090_abnormal_vision | 0.85666323 |
| 79 | MP0005535_abnormal_body_temperature | 0.84931461 |
| 80 | MP0001664_abnormal_digestion | 0.84453814 |
| 81 | MP0003632_abnormal_nervous_system | 0.83022789 |
| 82 | MP0008874_decreased_physiological_sensi | 0.82697875 |
| 83 | MP0001177_atelectasis | 0.81562399 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.79379696 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 0.77743755 |
| 86 | MP0002102_abnormal_ear_morphology | 0.77164094 |
| 87 | MP0005171_absent_coat_pigmentation | 0.76689307 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.75486430 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.71280822 |
| 90 | MP0004742_abnormal_vestibular_system | 0.70309518 |
| 91 | MP0004233_abnormal_muscle_weight | 0.69051011 |
| 92 | MP0003283_abnormal_digestive_organ | 0.68367948 |
| 93 | MP0002752_abnormal_somatic_nervous | 0.67833861 |
| 94 | MP0002653_abnormal_ependyma_morphology | 0.66707727 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.63531142 |
| 96 | MP0000639_abnormal_adrenal_gland | 0.62489377 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.61012904 |
| 98 | MP0005499_abnormal_olfactory_system | 0.61012904 |
| 99 | MP0005253_abnormal_eye_physiology | 0.60668437 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.60655869 |
| 101 | MP0006072_abnormal_retinal_apoptosis | 0.60516027 |
| 102 | MP0004130_abnormal_muscle_cell | 0.58778689 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.58496860 |
| 104 | MP0000026_abnormal_inner_ear | 0.56776601 |
| 105 | MP0004484_altered_response_of | 0.55454525 |
| 106 | MP0010769_abnormal_survival | 0.53326618 |
| 107 | MP0001943_abnormal_respiration | 0.53049851 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.52961979 |
| 109 | MP0002082_postnatal_lethality | 0.52289434 |
| 110 | MP0010770_preweaning_lethality | 0.52289434 |
| 111 | MP0003956_abnormal_body_size | 0.51225480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.92431990 |
| 2 | Myokymia (HP:0002411) | 5.89277625 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.67613700 |
| 4 | Focal seizures (HP:0007359) | 5.25769163 |
| 5 | Atonic seizures (HP:0010819) | 5.11538692 |
| 6 | Febrile seizures (HP:0002373) | 4.62880461 |
| 7 | Visual hallucinations (HP:0002367) | 4.47927412 |
| 8 | Hyperventilation (HP:0002883) | 4.45544170 |
| 9 | Absence seizures (HP:0002121) | 4.04018204 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.98617864 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.83803442 |
| 12 | Dialeptic seizures (HP:0011146) | 3.80787876 |
| 13 | Broad-based gait (HP:0002136) | 3.31353282 |
| 14 | Action tremor (HP:0002345) | 3.19087609 |
| 15 | Dysdiadochokinesis (HP:0002075) | 3.18991567 |
| 16 | Depression (HP:0000716) | 3.18140484 |
| 17 | Abnormal eating behavior (HP:0100738) | 3.17500982 |
| 18 | Anxiety (HP:0000739) | 3.11257712 |
| 19 | Cerebral hypomyelination (HP:0006808) | 3.11081947 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.10865310 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.01123826 |
| 22 | Truncal ataxia (HP:0002078) | 3.00621863 |
| 23 | Poor eye contact (HP:0000817) | 2.99504208 |
| 24 | Pheochromocytoma (HP:0002666) | 2.97205395 |
| 25 | Megalencephaly (HP:0001355) | 2.92213573 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 2.89517565 |
| 27 | Abnormality of the corticospinal tract (HP:0002492) | 2.89319957 |
| 28 | Diplopia (HP:0000651) | 2.88813381 |
| 29 | Abnormality of binocular vision (HP:0011514) | 2.88813381 |
| 30 | Hemiparesis (HP:0001269) | 2.77930257 |
| 31 | Akinesia (HP:0002304) | 2.75218805 |
| 32 | Postural instability (HP:0002172) | 2.74661642 |
| 33 | Delusions (HP:0000746) | 2.73288603 |
| 34 | Dysmetria (HP:0001310) | 2.72953028 |
| 35 | Ankle clonus (HP:0011448) | 2.72471045 |
| 36 | Supranuclear gaze palsy (HP:0000605) | 2.71461615 |
| 37 | Neuroendocrine neoplasm (HP:0100634) | 2.69765083 |
| 38 | Abnormal social behavior (HP:0012433) | 2.69738182 |
| 39 | Impaired social interactions (HP:0000735) | 2.69738182 |
| 40 | EEG with generalized epileptiform discharges (HP:0011198) | 2.68187521 |
| 41 | Polyphagia (HP:0002591) | 2.61097227 |
| 42 | Neurofibrillary tangles (HP:0002185) | 2.56494480 |
| 43 | Hypsarrhythmia (HP:0002521) | 2.55511178 |
| 44 | Drooling (HP:0002307) | 2.51614048 |
| 45 | Excessive salivation (HP:0003781) | 2.51614048 |
| 46 | Amblyopia (HP:0000646) | 2.49715446 |
| 47 | Tetraplegia (HP:0002445) | 2.49326098 |
| 48 | Sleep apnea (HP:0010535) | 2.49201037 |
| 49 | Papilledema (HP:0001085) | 2.48603572 |
| 50 | Gait imbalance (HP:0002141) | 2.45628326 |
| 51 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.43399217 |
| 52 | Aplasia of the phalanges of the hand (HP:0009802) | 2.43399217 |
| 53 | Aplasia involving bones of the extremities (HP:0009825) | 2.43399217 |
| 54 | Hemiplegia (HP:0002301) | 2.43329387 |
| 55 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.42165729 |
| 56 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.42165729 |
| 57 | Status epilepticus (HP:0002133) | 2.42052802 |
| 58 | Impaired smooth pursuit (HP:0007772) | 2.41094379 |
| 59 | Dysmetric saccades (HP:0000641) | 2.40888197 |
| 60 | Bradykinesia (HP:0002067) | 2.39738842 |
| 61 | Scanning speech (HP:0002168) | 2.36259128 |
| 62 | Peripheral hypomyelination (HP:0007182) | 2.35433712 |
| 63 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.34853033 |
| 64 | Torticollis (HP:0000473) | 2.34837331 |
| 65 | Clonus (HP:0002169) | 2.31786258 |
| 66 | Cerebral inclusion bodies (HP:0100314) | 2.30551743 |
| 67 | Resting tremor (HP:0002322) | 2.28926081 |
| 68 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.26426128 |
| 69 | Increased circulating renin level (HP:0000848) | 2.24870623 |
| 70 | Focal dystonia (HP:0004373) | 2.24077686 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.23712790 |
| 72 | Impaired vibratory sensation (HP:0002495) | 2.23655321 |
| 73 | Medial flaring of the eyebrow (HP:0010747) | 2.20455358 |
| 74 | Stereotypic behavior (HP:0000733) | 2.19457093 |
| 75 | Blue irides (HP:0000635) | 2.19266610 |
| 76 | Amyotrophic lateral sclerosis (HP:0007354) | 2.17023940 |
| 77 | Abnormal hair whorl (HP:0010721) | 2.15909950 |
| 78 | Neuronal loss in central nervous system (HP:0002529) | 2.15546549 |
| 79 | Spastic tetraplegia (HP:0002510) | 2.14251931 |
| 80 | Genetic anticipation (HP:0003743) | 2.13668236 |
| 81 | Fetal akinesia sequence (HP:0001989) | 2.12385375 |
| 82 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.09967273 |
| 83 | Failure to thrive in infancy (HP:0001531) | 2.09555897 |
| 84 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09529876 |
| 85 | Limb dystonia (HP:0002451) | 2.08109127 |
| 86 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.07671833 |
| 87 | Poor suck (HP:0002033) | 2.07510100 |
| 88 | CNS hypomyelination (HP:0003429) | 2.05825345 |
| 89 | Spastic gait (HP:0002064) | 2.05526369 |
| 90 | Progressive inability to walk (HP:0002505) | 2.05434571 |
| 91 | Absent speech (HP:0001344) | 2.03778724 |
| 92 | Protruding tongue (HP:0010808) | 2.02272112 |
| 93 | Gait ataxia (HP:0002066) | 2.01848929 |
| 94 | Muscular hypotonia of the trunk (HP:0008936) | 1.99256627 |
| 95 | Generalized myoclonic seizures (HP:0002123) | 1.97574993 |
| 96 | Postural tremor (HP:0002174) | 1.95832722 |
| 97 | Choreoathetosis (HP:0001266) | 1.95232370 |
| 98 | Abnormality of the lower motor neuron (HP:0002366) | 1.95072811 |
| 99 | Urinary urgency (HP:0000012) | 1.94419061 |
| 100 | Craniofacial dystonia (HP:0012179) | 1.94304163 |
| 101 | Narrow nasal bridge (HP:0000446) | 1.93941063 |
| 102 | Thickened helices (HP:0000391) | 1.93700214 |
| 103 | Specific learning disability (HP:0001328) | 1.93564440 |
| 104 | Spastic tetraparesis (HP:0001285) | 1.93402459 |
| 105 | Spinal canal stenosis (HP:0003416) | 1.93398900 |
| 106 | Lower limb muscle weakness (HP:0007340) | 1.91417925 |
| 107 | Apathy (HP:0000741) | 1.90748367 |
| 108 | Clumsiness (HP:0002312) | 1.90629575 |
| 109 | Inability to walk (HP:0002540) | 1.89376297 |
| 110 | Annular pancreas (HP:0001734) | 1.89146687 |
| 111 | Split foot (HP:0001839) | 1.87899343 |
| 112 | Rigidity (HP:0002063) | 1.87555208 |
| 113 | Intention tremor (HP:0002080) | 1.86883898 |
| 114 | Agitation (HP:0000713) | 1.86512629 |
| 115 | Incomplete penetrance (HP:0003829) | 1.83928356 |
| 116 | Psychosis (HP:0000709) | 1.81496344 |
| 117 | Prolonged QT interval (HP:0001657) | 1.79663475 |
| 118 | Limb ataxia (HP:0002070) | 1.79399939 |
| 119 | Menstrual irregularities (HP:0000858) | 1.78901297 |
| 120 | Hyperthyroidism (HP:0000836) | 1.77747585 |
| 121 | Obstructive sleep apnea (HP:0002870) | 1.77132476 |
| 122 | Mutism (HP:0002300) | 1.76645214 |
| 123 | Bundle branch block (HP:0011710) | 1.76490518 |
| 124 | Abnormality of saccadic eye movements (HP:0000570) | 1.74268382 |
| 125 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.74196000 |
| 126 | Diminished motivation (HP:0000745) | 1.74053799 |
| 127 | Diminished movement (HP:0002374) | 1.71747892 |
| 128 | Ventricular fibrillation (HP:0001663) | 1.70912558 |
| 129 | Abnormal EKG (HP:0003115) | 1.70859114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.97454517 |
| 2 | CASK | 4.44930626 |
| 3 | NTRK3 | 4.11311631 |
| 4 | MAP3K9 | 2.77509643 |
| 5 | DAPK2 | 2.77135042 |
| 6 | MAP3K4 | 2.69943262 |
| 7 | MAP2K7 | 2.66941991 |
| 8 | MAP3K12 | 2.29370025 |
| 9 | PRPF4B | 2.14913124 |
| 10 | NTRK2 | 2.08228555 |
| 11 | MINK1 | 2.02572884 |
| 12 | CDK19 | 1.99150326 |
| 13 | PRKD3 | 1.91813636 |
| 14 | DAPK1 | 1.86147187 |
| 15 | PLK2 | 1.77784720 |
| 16 | MARK1 | 1.75117008 |
| 17 | MAP2K4 | 1.64021327 |
| 18 | TNIK | 1.60962378 |
| 19 | PAK6 | 1.55111205 |
| 20 | KSR2 | 1.54748911 |
| 21 | CAMKK1 | 1.43167669 |
| 22 | AKT3 | 1.43054353 |
| 23 | FRK | 1.42610093 |
| 24 | CDK5 | 1.40028461 |
| 25 | CCNB1 | 1.39105990 |
| 26 | LMTK2 | 1.38167156 |
| 27 | SGK494 | 1.34811133 |
| 28 | SGK223 | 1.34811133 |
| 29 | RIPK4 | 1.34151642 |
| 30 | PRKCG | 1.33139359 |
| 31 | SGK2 | 1.33125255 |
| 32 | PHKG2 | 1.32856187 |
| 33 | PHKG1 | 1.32856187 |
| 34 | NTRK1 | 1.31821860 |
| 35 | ARAF | 1.31126228 |
| 36 | GRK5 | 1.29769213 |
| 37 | KSR1 | 1.23532612 |
| 38 | MAPK13 | 1.22622477 |
| 39 | CAMKK2 | 1.20727673 |
| 40 | OXSR1 | 1.15791478 |
| 41 | CAMK2A | 1.04080820 |
| 42 | MAP3K13 | 1.03665678 |
| 43 | MUSK | 1.03384338 |
| 44 | SGK3 | 0.97472006 |
| 45 | FGFR2 | 0.97232143 |
| 46 | MAP3K2 | 0.96861572 |
| 47 | SIK3 | 0.94395575 |
| 48 | PINK1 | 0.94359140 |
| 49 | WNK3 | 0.94173689 |
| 50 | UHMK1 | 0.93229978 |
| 51 | PRKCH | 0.90130092 |
| 52 | STK38 | 0.89758693 |
| 53 | FES | 0.88231832 |
| 54 | CAMK2B | 0.86969554 |
| 55 | CSNK1G3 | 0.86884412 |
| 56 | LIMK1 | 0.85462521 |
| 57 | PTK2B | 0.83426685 |
| 58 | CAMK1 | 0.82378146 |
| 59 | PKN1 | 0.82311804 |
| 60 | CDK18 | 0.80767072 |
| 61 | DYRK2 | 0.80755737 |
| 62 | PRKCE | 0.80704198 |
| 63 | SIK2 | 0.78610645 |
| 64 | CSNK1A1L | 0.77855060 |
| 65 | BMPR2 | 0.76576862 |
| 66 | CDK15 | 0.76132309 |
| 67 | MAP4K2 | 0.74472487 |
| 68 | CDK14 | 0.73238307 |
| 69 | PDK3 | 0.73074877 |
| 70 | PDK4 | 0.73074877 |
| 71 | BRAF | 0.72668091 |
| 72 | SGK1 | 0.72461789 |
| 73 | CSNK1G1 | 0.71263527 |
| 74 | INSRR | 0.69316276 |
| 75 | DYRK1A | 0.67863160 |
| 76 | TSSK6 | 0.66294836 |
| 77 | NME1 | 0.64873910 |
| 78 | CDK11A | 0.63833418 |
| 79 | TYRO3 | 0.63360379 |
| 80 | BCR | 0.61480261 |
| 81 | PRKCZ | 0.61176592 |
| 82 | MAP3K1 | 0.60937503 |
| 83 | ERBB3 | 0.60187577 |
| 84 | LATS2 | 0.57363170 |
| 85 | PAK3 | 0.56827965 |
| 86 | PDPK1 | 0.56346257 |
| 87 | MAPK10 | 0.55687525 |
| 88 | PDK1 | 0.52978861 |
| 89 | CAMK2D | 0.52606072 |
| 90 | CAMK2G | 0.51721140 |
| 91 | STK11 | 0.50824344 |
| 92 | TESK1 | 0.48663560 |
| 93 | MAPK7 | 0.48359184 |
| 94 | DAPK3 | 0.47803308 |
| 95 | ALK | 0.47774375 |
| 96 | RET | 0.47267502 |
| 97 | RAF1 | 0.47041809 |
| 98 | RIPK1 | 0.46579746 |
| 99 | ADRBK1 | 0.45128678 |
| 100 | RPS6KA3 | 0.44703945 |
| 101 | NEK6 | 0.44666879 |
| 102 | TNK2 | 0.44519821 |
| 103 | MAPK12 | 0.44489376 |
| 104 | FER | 0.44306734 |
| 105 | MARK2 | 0.43628993 |
| 106 | MAP2K6 | 0.43580811 |
| 107 | CDC42BPA | 0.43201116 |
| 108 | CAMK4 | 0.43133315 |
| 109 | MAP2K1 | 0.43048472 |
| 110 | PRKG1 | 0.43036373 |
| 111 | TRIM28 | 0.42220678 |
| 112 | MAP3K11 | 0.41873363 |
| 113 | ROCK2 | 0.41113835 |
| 114 | PDK2 | 0.37688968 |
| 115 | CDK3 | 0.37561568 |
| 116 | PNCK | 0.37544761 |
| 117 | CSNK1D | 0.37045338 |
| 118 | CSNK1A1 | 0.36766174 |
| 119 | PRKACA | 0.36600361 |
| 120 | PRKAA1 | 0.36119207 |
| 121 | NEK1 | 0.35645799 |
| 122 | CSNK1G2 | 0.35577483 |
| 123 | FGR | 0.35033326 |
| 124 | PRKCA | 0.34614464 |
| 125 | OBSCN | 0.33660217 |
| 126 | TAOK1 | 0.32122289 |
| 127 | CSNK1E | 0.30728381 |
| 128 | ROCK1 | 0.29883465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.82938860 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.65667768 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.82066057 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.74865114 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.69840563 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.65162873 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.59733484 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.49723881 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.40356496 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.40264821 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.38147515 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.28464114 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.06338672 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.00399869 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.90679157 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.86300392 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.78021778 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76733742 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67730836 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.65063892 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64014103 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.58659837 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.58318194 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.57544999 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57380255 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.45886687 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40624862 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39636748 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38405990 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37279008 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.35173495 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.29623303 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20949480 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14111672 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14072434 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.13805941 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13130657 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09858449 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07079940 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.00425405 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98618005 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96802220 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95121869 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93830842 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92607160 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92384256 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89630654 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89505511 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88800223 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88140256 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85405937 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 0.83003672 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82047650 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80485676 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 0.75621934 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74995420 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.74509811 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74010427 |
| 59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73254098 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71327720 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.68835507 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66745751 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65292124 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62222981 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62165959 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61308008 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60549033 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59643299 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58594800 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58316246 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57606031 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57100122 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55688353 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55564365 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53582868 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.53374083 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53348023 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51698634 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.51486470 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49563852 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48548027 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47097301 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46905748 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.46027347 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45659256 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44733081 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.43222155 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.43205681 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41526823 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41118553 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40328396 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40019126 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39344150 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38132349 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37583849 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35314703 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.35057092 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34678576 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33138927 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.31443151 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31280506 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31219364 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31156333 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30070472 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29378034 |
| 106 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.28879875 |
| 107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28850320 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28148323 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27252100 |
| 110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26590967 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.26262169 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25697935 |
| 113 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.25109420 |
| 114 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.24760632 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24045741 |

